CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
39.25
+0.32 (0.82%)
Nov 20, 2026, 2:23 PM EST - Market open
CRISPR Therapeutics AG Employees
CRISPR Therapeutics AG had 393 employees as of December 31, 2024. The number of employees decreased by 14 or 3.44% compared to the previous year. That makes CRISPR Therapeutics AG the 21,936th largest employer in the world and 2,846th in the United States.
Employees
393
Change (1Y)
-14
Growth (1Y)
-3.44%
Revenue / Employee
$64,051
Profits / Employee
-$1,160,649
Market Cap
3.81B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 393 | -14 | -3.44% |
| Dec 31, 2023 | 407 | -51 | -11.14% |
| Dec 31, 2022 | 458 | -15 | -3.17% |
| Dec 31, 2021 | 473 | 63 | 15.37% |
| Dec 31, 2020 | 410 | 106 | 34.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| AbCellera Biologics | 562 |
| Tarsus Pharmaceuticals | 370 |
| Xenon Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Relay Therapeutics | 218 |
| Disc Medicine | 173 |
| Parabilis Medicines | 145 |
CRSP News
- 3 days ago - CRISPR Therapeutics AG Transcript: Jefferies Global Healthcare Conference - Transcripts
- 10 days ago - CRISPR Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 11 days ago - CRISPR Therapeutics Presents Phase 1b Data for CTX310® Demonstrating Reductions in ANGPTL3 and Triglycerides in Patients with Severe Hypertriglyceridemia at the American Heart Association (AHA) Scientific Sessions 2026 - GlobeNewsWire
- 12 days ago - CRISPR Therapeutics Provides Update on Zugocabtagene Geleucel (Zugo-cel) in Refractory Rheumatologic Autoimmune Diseases - GlobeNewsWire
- 16 days ago - CRISPR Therapeutics to Present Clinical Data from Zugo-cel in Large B-Cell Lymphoma at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition - GlobeNewsWire
- 16 days ago - Crispr Therapeutics price target lowered to $80 from $81 at BofA - TheFly
- 16 days ago - Crispr Therapeutics price target raised to $90 from $88 at Citi - TheFly
- 16 days ago - Crispr Therapeutics price target lowered to $70 from $75 at Wells Fargo - TheFly